• Gastroenterology · Apr 2002

    Multicenter Study

    Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.

    • Richard Moreau, Francois Durand, Thierry Poynard, Christian Duhamel, Jean-Paul Cervoni, Philippe Ichaï, Armand Abergel, Chantal Halimi, Mathieu Pauwels, Jean-Pierre Bronowicki, Emile Giostra, Cathy Fleurot, Danielle Gurnot, Olivier Nouel, Philippe Renard, Michel Rivoal, Pierre Blanc, Dimitri Coumaros, Sylvie Ducloux, Stephane Levy, Alexandre Pariente, Jean-Marc Perarnau, Jean Roche, Myriam Scribe-Outtas, Dominique Valla, Brigitte Bernard, Didier Samuel, Joël Butel, Antoine Hadengue, Andrzej Platek, Didier Lebrec, and Jean-Francois Cadranel.
    • INSERM U-481 et Service d'Hépatologie, Hôpital Beaujon, Clichy, France. moreau@bichat.inserm.fr
    • Gastroenterology. 2002 Apr 1; 122 (4): 923-30.

    Background & AimsType 1 hepatorenal syndrome (HRS) is a severe complication of cirrhosis associated with a short median survival time (<2 weeks). Although the administration of terlipressin improves renal function, its effect on survival is unknown. This study investigated predictive factors of survival in patients with type 1 HRS treated with terlipressin.MethodsNinety-nine patients with type 1 HRS treated with terlipressin in 24 centers were retrospectively studied. Terlipressin-induced improved renal function was defined as a decrease in serum creatinine value to <130 micromol/L or a decrease of at least 20% at the end of treatment.ResultsAt inclusion, the Child-Pugh score was 11.8 +/- 1.6 (mean +/- SD). Terlipressin (3.2 +/- 1.3 mg/day) was administered for 11 +/- 12 days. Renal function improved in 58% of patients (serum creatinine decreased by 46% +/- 17% from 272 +/- 114 micromol/L). Median survival time was 21 days. Survival rate was 40% at 1 month. Multivariate analysis showed that improved renal function and Child-Pugh score < or =11 at inclusion were independent predictive factors of survival (P < 0.0001 and 0.02, respectively). Thirteen patients underwent liver transplantation (92 +/- 95 days after HRS onset), 10 of whom had received terlipressin and had had improved renal function.ConclusionsThis retrospective uncontrolled study shows that in patients with type 1 HRS, terlipressin-induced improved renal function is associated with an increase in survival. Thus, a randomized trial investigating the effect of terlipressin on survival in patients with type 1 HRS should be performed.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…